Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLX | Deferred Stock Units | Award | $0 | +48 | +0.7% | $0.00 | 6.89K | Nov 10, 2021 | Common Stock | 48 | Direct | F1, F2, F3 | |
transaction | CLX | Deferred Stock Units | Award | $0 | +148 | +2.14% | $0.00 | 7.04K | Dec 31, 2021 | Common Stock | 148 | Direct | F1, F3, F4 | |
transaction | CLX | Deferred Stock Units | Award | $0 | +919 | +13.06% | $0.00 | 7.95K | Dec 31, 2021 | Common Stock | 919 | Direct | F1, F3, F5 |
Id | Content |
---|---|
F1 | 1-for-1 |
F2 | Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. |
F3 | The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. |
F4 | Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. |
F5 | Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. |